Novo Nordisk Introduces NovoCare® Pharmacy, Lowering Cost Of All Doses Of FDA-approved Wegovy® (semaglutide) To $499 Per Month And Offering Easy Home Delivery For Cash-paying Patients

Published Date: Wed, 05 Mar 2025 13:00:00 GMT | By PR Newswire On https://www.prnewswire.com

Upcomingweb USA Business Latest News - NovoCare® Pharmacy provides direct-to-patient, convenient home shipments of all dose strengths of Wegovy® at a reduced cost of $499 per month for cash-paying...